Search Results - "Buabeng PBY"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Could Less Be More? Accounting for Fractional-Dose Regimens and Different Number of Vaccine Doses When Measuring the Impact of the RTS,S/AS01E Malaria Vaccine.

    Authors: Westercamp N Osei-Tutu L Schuerman L et al.

    Source: The Journal of infectious diseases [J Infect Dis] 2024 Aug 16; Vol. 230 (2), pp. e486-e495.

    Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II

    Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  2. 2

    Sustained efficacy of the RTS,S/AS01E malaria vaccine over 50 months of follow-up when used in full-dose or fractional-dose regimens in young children in Ghana and Kenya: final results from an open-label, phase 2b, randomised controlled trial.

    Authors: Osei-Tutu L Kariuki SK Lee CK et al.

    Corporate Authors: Osei-Tutu L Kariuki SK Lee CK et al.

    Source: The Lancet. Global health [Lancet Glob Health] 2025 Oct; Vol. 13 (10), pp. e1723-e1736.

    Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study

    Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101613665 Publication Model: Print Cited Medium: Internet ISSN: 2214-109X (Electronic) Linking ISSN: 2214109X NLM ISO Abbreviation: Lancet Glob Health Subsets: MEDLINE

    Save to List
  3. 3

    Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial.

    Authors: Agbenyega T Schuind AE Adjei S et al.

    Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2025 Aug; Vol. 25 (8), pp. 861-872. Date of Electronic Publication: 2025 Mar 19.

    Publication Type: Clinical Trial, Phase III; Equivalence Trial; Journal Article; Randomized Controlled Trial

    Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE

    Save to List
  4. 4

    Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5-17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial.

    Authors: Juraska M Early AM Li L et al.

    Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Sep; Vol. 24 (9), pp. 1025-1036. Date of Electronic Publication: 2024 May 06.

    Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE

    Save to List
  5. 5

    Baseline malaria infection status and RTS,S/AS01E malaria vaccine efficacy.

    Authors: Juraska M Early AM Li L et al.

    Source: MedRxiv : the preprint server for health sciences [medRxiv] 2023 Nov 23. Date of Electronic Publication: 2023 Nov 23.

    Publication Type: Preprint; Journal Article

    Journal Info: Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE

    Save to List
  6. 6

    Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5-17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial.

    Authors: Samuels AM Ansong D Kariuki SK et al.

    Corporate Authors: Samuels AM Ansong D Kariuki SK et al.

    Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Sep; Vol. 22 (9), pp. 1329-1342. Date of Electronic Publication: 2022 Jun 23.

    Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

    Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE

    Save to List

Search Tools: